Evidence map›Paper›PMID 35408803›Full record

ArticleInternational journal of molecular sciences2022

Transcriptional and Distributional Profiling of Microglia in Retinal Angiomatous Proliferation.

Anja Schlecht, Julian Wolf, Stefaniya Boneva, Gabriele Prinz, Barbara M Braunger, Peter Wieghofer, Hansjürgen Agostini, Günther Schlunck, Clemens Lange

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Hyalocytes-guardians of the vitreoretinal interface.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Anja SchlechtEye Center, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.ORCID 0000-0003-3336-9982
Julian WolfEye Center, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Stefaniya BonevaEye Center, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.ORCID 0000-0002-9811-2160
Gabriele PrinzEye Center, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Barbara M BraungerInstitute of Anatomy and Cell Biology, Julius-Maximilians-University Wuerzburg, 97070 Wuerzburg, Germany.
Peter WieghoferCellular Neuroanatomy, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, 86159 Augsburg, Germany.
Hansjürgen AgostiniEye Center, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Günther SchlunckEye Center, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Clemens LangeEye Center, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
University of Freiburg · DEUniversity of Augsburg · DEUniversity of Würzburg · DE

Funding

Novartis (Germany) Not applicable
6 · The paper itself

Abstract

Macular neovascularization type 3, formerly known as retinal angiomatous proliferation (RAP), is a hallmark of age-related macular degeneration and is associated with an accumulation of myeloid cells, such as microglia (MG) and infiltrating blood-derived macrophages (MAC). However, the contribution of MG and MAC to the myeloid cell pool at RAP sites and their exact functions remain unknown. In this study, we combined a microglia-specific reporter mouse line with a mouse model for RAP to identify the contribution of MG and MAC to myeloid cell accumulation at RAP and determined the transcriptional profile of MG using RNA sequencing. We found that MG are the most abundant myeloid cell population around RAP, whereas MAC are rarely, if ever, associated with late stages of RAP. RNA sequencing of RAP-associated MG showed that differentially expressed genes mainly contribute to immune-associated processes, including chemotaxis and migration in early RAP and proliferative capacity in late RAP, which was confirmed by immunohistochemistry. Interestingly, MG upregulated only a few angiomodulatory factors, suggesting a rather low angiogenic potential. In summary, we showed that MG are the dominant myeloid cell population at RAP sites. Moreover, MG significantly altered their transcriptional profile during RAP formation, activating immune-associated processes and exhibiting enhanced proliferation, however, without showing substantial upregulation of angiomodulatory factors.

Indexed as

Macular DegenerationRetinal NeovascularizationAnimalsCell ProliferationFluorescein AngiographyMiceMicrogliaNeovascularization, PathologicTomography, Optical CoherenceAMDCreERT2Cx3cr1Mactel 2macular neovascularizationmicrogliaMNV type 3RAPretinal angiomatous proliferationRNA sequencing

Identifiers

PMID35408803
PMCPMC8998238
OpenAlexW4220821268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.